ArticleBriefings in bioinformatics2025
Identification of key candidate genes for ovarian cancer using integrated statistical and machine learning approaches.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Repurposing natural compounds: computational evaluation ofFrontiers in bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ovarian cancer (OC) is a highly lethal malignancy worldwide, necessitating the identification of key genes to uncover its molecular mechanisms and improve diagnostic and therapeutic strategies. This study utilized statistical and machine learning approaches to identify key candidate genes for OC. Three microarray datasets were obtained from the gene expression omnibus database, and analysis began with normalization and differential gene expression analysis using the Limma package. Highly discriminative differentially expressed genes (HDDEGs) were identified through a support vector machine-based approach, yielding 84 overlapping HDDEGs across the datasets. Enrichment analysis of HDDEGs was conducted using DAVID. A protein-protein interaction network constructed via STRING pinpointed central hub genes using CytoHubba metrics. Significant modules were analyzed with molecular complex detection, identifying 18 central hub genes, 11 hub module genes, and 54 meta-hub genes. The intersection of these three gene sets revealed eight shared key genes (FANCD2, BUB1B, BUB1, KIF4A, DTL, NCAPG, KIF20A, and UBE2C). Weighted gene co-expression network analysis identified key modules linked to clinical traits and confirmed grouping eight key candidate genes into a single cluster. These genes were validated using two independent datasets (GSE38666 and TCGA-OC), with area under the curve and survival analyses underscoring their predictive and prognostic significance in OC. This integrative approach advances understanding of OC's molecular basis, identifies potential biomarkers, and emphasizes the clinical relevance of the eight key candidate genes for OC diagnosis, prognosis, and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.